Strong impact of nocturia on sleep quality in patients with lower urinary tract symptoms (original) (raw)
Related papers
Korean Journal of Andrology, 2012
Purpose: Nocturia is one of the most bothersome lower urinary tract symptoms (LUTS). The aim of the present study is to determine whether severe-nocturia have impact on the abnormal daytime sleepiness in men with LUTS/benign prostate hyperplasia (BPH). Materials and Methods: Severe-nocturia was classified as twice or more per night. A total of 85 men met the criteria and constituted the study cohort. The patients had a detailed clinical evaluation, including a complete history, physical examination, urine analysis, urine culture, a digital rectal examination, serum prostate-specific antigen (PSA) level, prostate volume by transrectal ultrasonography, uroflowmetry and postvoid residual urine volume. LUTS and symptom-specific quality of life (QoL) were assessed using the IPSS. Patients were asked to complete an Epworth Sleepiness Scale questionnaire for daytime sleepiness. Results: 43 patients had less than one, 42 patients had more than two episodes of nocturia. There was no significant difference of age, total prostate volume, PSA levels between patients with mild-nocturia and severe-nocturia. There was no significant difference of maximum flow rate (Qmax), voided volume and postvoid residual urine volume (PVR) between patients with mild-nocturia and severe-nocturia. There was significant decrease of total International Prostate Symptom Score (IPSS) scores and QoL index in patients with severe-nocturia compared in patients with mild-nocturia. The number of patients with abnormal daytime sleepiness in mild-nocturia and severe-nocturia were 4.7% (2/43), 16.7% (7/42), respectively (p＜0.05). Regression coefficiency between percent of nocturia and total score of daytime sleepiness was significant (p＜0.05) and regression coefficient (R) was 0.29. Conclusions: Our results indicate that severe-nocturia had impact on the abnormal daytime sleepiness in patients with LUTS.
BMJ open, 2012
The objective of this study is to assess the impact of nocturia on sleep in patients with lower urinary tract symptoms (LUTS)/benign prostatic enlargement (BPE) (nocturia≥2). Cross-sectional survey. 798 urologists and general practitioners randomly selected from the overall population of urologists and general practitioners of every French region. A total of 2179 LUTS/BPE men (aged 67.5±7.5 years old) were recruited. Validated patients' self-administered questionnaires were used to assess the severity of LUTS/BPE (the International Prostate Symptom Score), sleep characteristics (sleep log) and sleep disorders (the International Classification of Sleep Disorders (ICSD-2) and the DSM-IV). Sleepiness was assessed with the Epworth Sleepiness Scale (ESS). The volume of 24 h diuresis (<or >1500 ml) was measured. Participants had on average 2.9±0.9 nocturia episodes (three or more episodes in 67%) and the International Prostate Symptom Score of 15.8±5.7; 60.9% complained of insom...
Sleep Analysis of Patients With Nocturia and Benign Prostatic Obstruction
Urology, 2012
OBJECTIVE To analyze the timing of nocturia during sleep and its effect on sleep quality using the polysomnography (PSG) findings from patients with benign prostatic obstruction. METHODS From August 2009 to August 2010, 20 patients diagnosed with benign prostatic obstruction were enrolled in the present study. The sleep evaluation was performed by PSG. The Epworth index was used to evaluate the sleepiness of the patients. The effect of nocturia on sleep quality is evaluated by sleep efficacy, total sleep time, and rapid eye movement sleep duration, calculated from the hypnograms derived from the polysomnograms. RESULTS The mean age, total International Prostate Symptom Score, nocturia frequency on International Prostate Symptom Score, and frequency of nocturia recorded during PSG was 60.4 Ϯ 8.5 years (range 44-74), 19.3 Ϯ 4.9 (range 10-28), 3.5 Ϯ 1.05 (range 2-5), and 1.35 Ϯ 1.2 (range 0-4), respectively. In 6 patients (30%), the Epworth sleepiness score was pathologic (score Ͼ8). Nocturia correlated positively with increased daytime sleepiness, however it did not correlate with sleep efficacy or total sleep time. These parameters were affected by the apnea-hypopnea index, the major determinant of obstructive sleep apnea. Of the 20 patients, 14 (70%) experienced nocturia during PSG, and in these patients, we recorded 23 nocturia episodes that mostly occurred in the superficial sleep stage (16 [70%] of 23). Only 7 nocturia episodes (30%) occurred in the deep sleep stage. The sleep quality of patients with deep sleep nocturia did not differ from that of patients with superficial sleep nocturia. CONCLUSION The results of our study have shown that nocturia predominantly occurs during the superficial sleep or rapid eye movement stage and is related to increased daytime sleepiness in patients with benign prostatic obstruction. The timing and frequency of nocturia had no significant affect on sleep quality; however, the presence of obstructive sleep apnea negatively interfered with these parameters. UROLOGY 80: 383-388, 2012.
Sleep Quality and Lower Urinary Tract Symptoms Among Patients with Prostatic Diseases
Annals of African Surgery, 2020
Background: Incidence of symptomatic prostatic diseases increases with age. Nocturia disturbs sleep. We set out to determine the quality of sleep and severity of lower urinary tract symptoms (LUTS) and bother score in patients with benign prostatic hyperplasia (BPH) and carcinoma of the prostate (CAP). Methods: A cross-sectional study of new patients seen in the urology outpatient clinic with bladder outlet obstruction (BOO) from either BPH or CAP over a period of 18 months. Patients were interviewed using Pittsburgh Sleep Quality Index (PSQI) and International prostate symptoms score (IPSS) questionnaires. Data obtained were analyzed using SPSS version 23. Results:168 patients were interviewed. CAP patients were older than their BPH counterparts. About 45% of the patients had poor sleep quality. CAP patients (52.9%) were more of poor sleepers compared with BPH patients (40.0%). CAP patients (46.3%) had more severe IPSS than BPH patients (33.3%). Both CAP (70.6%) and BPH (76.0%) pat...
Effect of Nocturia on Quality of Life among Clients with Benign Prostatic Hyperplasia
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine, 2021
Benign Prostatic Hyperplasia (BPH) and its associated symptom nocturia have a significant impact on quality of life (QoL). It occurs predominantly in men as age increases. Zhang et al. [1] observed that nocturia significantly impacted the QoL when the patient had 2 or more episodes each night. Despite its negative impact on the QoL, the middle adulthood group has rarely been considered. Therefore the aim of this study was to assess the QoL among adult clients with BPH based on the severity of nocturia. In this study, it was seen that patients with BPH had low QoL, and the severity of nocturia had a significant perfect correlation with their QoL. Interrupted sleep associated with night‑time voiding could lead to tiredness during the day, reduced cognitive performance, and increased susceptibility for other ailments. Patients with LUTS/BPH view nocturia as a very bothersome affliction, thus impairing their QoL. Therefore, an appropriate treatment for LUTS/BPH that minimizes these symptoms is necessary. Enhancing sleep quality by alleviating the symptoms of nocturia can result in a better QoL for the patient
Journal of Urological Surgery, 2020
What is known on the subject? and What does the study add? Nocturia related to benign prostatic hyperplasia (BPH) is one of the most disturbing symptoms.Sleep disturbance, awaken short of breathor with headache, quantity of sleep, sleep adequacy, and somnolans are adversely affected in BPH patients.In this study,we aimed to evaluate the sleep quality and quantity in patients with BPH by Medical Outcomes Study-Sleep Scale (MOS-SS).To the best of our knowledge, this is the first study to evaluate the usability of this scale in urology practice.According to our findings,it is important to evaluate the subdomains of sleep quality and quantity,especially in patients with increased PVR and decreased Qmaximum, Qaverage, voiding volume.
Determining the quality of life and the sleep quality in patients with benign prostate hyperplasia
International Journal of Urological Nursing, 2019
Research question: How is the quality of life and quality of sleep affected in patients with benign prostatic hyperplasia? Research problem: The aim of this study was to evaluate the quality of life and quality of sleep in patients with benign prostatic hyperplasia (BPH) and to identify the relationship between them. Nocturia is one of the main symptoms associated to BPH, causing significant sleep disturbances, including sleep interruptions. Such sleep interruptions may significantly impair quality of life. Literature review: The assessment of nocturia and its impact on quality of life and sleep quality in patients living with benign prostatic hyperplasia (BPH) has been poor in terms of clinical research; moreover, there is a lack of specific methods to assess this impact. Methodology: The sample of this descriptive study consisted of all patients with the diagnosis of BPH who were admitted to the urology outpatient clinic of a state hospital in Turkey. The data were collected from 212 patients with BPH who accepted to participate in the study in January-June 2018. All patients gave consent prior to inclusion in the study. The Pittsburgh Sleep Quality Index and the WHOQOL-BREF (World Health Organization Quality of Life Scale-Brief Form) were used as the principle data collection tools. Percentage, t test, correlation and one-way variance analysis test were used to evaluate the data. Results: The mean age of the patients was 67.50 ± 8.89 years and 63.2% of them were first diagnosed with benign prostatic hyperplasia 2.13 years ago. The lowest and the highest average scores that the patients obtained from the WHOQOL-BREF were their social and environmental domains scores, respectively. In all, 20.2% of the patient were found to have poor sleep quality (global score ≥ 5). The results showed that there was a positive correlation between the mean scores of the sleep quality of the patients and their quality of life physical domain subscale. It was also found that there was a significant negative correlation between night urination and the sleep quality in BPH patients (P < .05). Conclusions: It was determined that low quality of life in BPH patients is associated with low sleep quality. Personal characteristics, frequent night urination and working
Nature and Science of Sleep, 2013
Objectives: This study examined the association between sleep disorders and lower urinary tract symptoms in patients who had visited urology departments. Methods: This was an independent cross-sectional, observational study. Outpatients who had visited the urology departments at the Kinki University School of Medicine or the Sakai Hospital, Kinki University School of Medicine, between August 2011 and January 2012 were assessed using the Athens Insomnia Scale and the International Prostate Symptom Score. Results: In total, 1174 patients (mean age, 65.7 ± 13.7 years), with 895 men (67.1 ± 13.2 years old) and 279 women (61.4 ± 14.6 years old), were included in the study. Approximately half of these patients were suspected of having a sleep disorder. With regard to the International Prostate Symptom Score subscores, a significant increase in the risk for suspected sleep disorders was observed among patients with a post-micturition symptom (the feeling of incomplete emptying) subscore of 1(a2.3−foldincrease),astoragesymptom(daytimefrequency+urgency+nocturia)subscoreof1 (a 2.3-fold increase), a storage symptom (daytime frequency + urgency + nocturia) subscore of 1(a2.3−foldincrease),astoragesymptom(daytimefrequency+urgency+nocturia)subscoreof5 (a 2.7-fold increase), a voiding symptom (intermittency + slow stream + hesitancy) subscore of 2(a2.6−foldincrease),andanocturiasubscoreof2 (a 2.6-fold increase), and a nocturia subscore of 2(a2.6−foldincrease),andanocturiasubscoreof2 (a 1.9-fold increase).